Testing a new long-acting insulin in type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study compares a new investigational long-acting insulin (GZR33) to an approved one (insulin degludec) in people with type 1 diabetes. You would receive both insulins during an inpatient 'clamp' procedure to see how well they work, which may help find a more affordable or convenient option for daily blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes for at least 1 year.
- You are between 18 and 64 years old.
- Your average blood sugar (A1C) is 9.0% or lower.
- Your body mass index (BMI) is between 18.5 and 29.0.
- You have been on the same insulin routine (stable dose) for at least 2 months, using between 0.2 and 1.2 units per kilogram of body weight each day.
- You have not had more than 1 severe low blood sugar event needing help in the last 6 months, and you are aware of low blood sugar symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
This study tests an investigational medicine called GZR101-80 for people with type 2 diabetes. It aims to see how well it controls blood sugar and how safe it is.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
This study checks whether two versions of an experimental medication (called GZR4) are the same in how they work in the body. It involves healthy adults and is a Phase 1 trial, meaning it's one of the first steps in testing a drug in humans.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Hear when a new Type 1 Diabetes Mellitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.